MORTATO, EDOARDO
MORTATO, EDOARDO
Università degli Studi di Roma Tor Vergata
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: The EARLY study
2025-01-01 Mortato, E; Talamonti, M; Marcelli, L; Megna, M; Raimondo, A; Caldarola, G; Bernardini, N; Balato, A; Campanati, A; Esposito, M; Bonifati, C; Lora, V; Potestio, L; Lembo, S; Loconsole, F; De Luca, E; Skroza, N; Buononato, D; Bianchelli, T; Fargnoli, Mc; Tommasino, N; Primavera, F; De Simone, C; Bianchi, L; Galluzzo, M
AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks
2026-03-13 Mortato, E; Talamonti, M; Savastano, L; Marcelli, L; Tofani, L; Gneo, V; Marrapodi, D; Ingrosso, Mr; Bianchi, L; Galluzzo, M
Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life Study
2025-06-01 Mortato, E; Talamonti, M; Paganini, C; Belcastro, A; Tofani, L; Bianchi, L; Galluzzo, M
Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study
2025-01-01 Mortato, E; Marcelli, L; Tofani, L; Belcastro, A; Talamonti, M; Paganini, C; Di Raimondo, C; Bianchi, L; Galluzzo, M
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
2025-05-13 Gioacchini, H; Rossi, A; Esposito, M; Vagnozzi, E; Fargnoli, Mc; Gisondi, P; Bellinato, F; Assorgi, C; Brianti, P; Mercuri, Sr; Burlando, M; Cozzani, E; Brunasso, G; Caccavale, S; Balato, A; Caldarola, G; De Simone, C; Campione, E; Giunta, A; Tonon, F; Venturini, M; Carrera, Cg; Marzano, Av; Carugno, A; Sena, P; Costanzo, A; Narcisi, A; Cusano, F; Dapavo, P; Quaglino, P; Dattola, A; Richetta, Ag; Gaiani, F; Malagoli, P; Megna, M; Potestio, L; Mortato, E; Loconsole, F; Romano, F; Faragalli, A; Gesuita, R; Bianchelli, T; Diotallevi, F; Orsini, D; Campanati, A
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis
2026-01-06 Mortato, E; Marcelli, L; Panichelli, A; Talamonti, M; Gneo, V; Marrapodi, D; Di Raimondo, C; Bianchi, L; Galluzzo, M
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
2025-01-01 Mortato, E; Talamonti, M; Marcelli, L; Megna, M; Raimondo, A; Caldarola, G; Bernardini, N; Balato, A; Campanati, A; Esposito, M; Bonifati, C; Lora, V; Potestio, L; Lembo, S; Loconsole, F; De Luca, E; Skroza, N; Buononato, D; Bianchelli, T; Fargnoli, Mc; Tommasino, N; Primavera, F; De Simone, C; Bianchi, L; Galluzzo, M
Predictive Factors of Super-Responder Status to Dupilumab in Adult Atopic Dermatitis: A Real-World Monocentric Study
2026-01-01 Mortato, E; Talamonti, M; Paganini, C; Belcastro, A; Tofani, L; Bianchi, L; Galluzzo, M
Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies
2025-01-01 Paganini, C; Mortato, E; Tofani, L; Belcastro, A; Talamonti, M; Di Raimondo, C; Bianchi, L; Galluzzo, M
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis)
2025-05-15 Esposito, M; Gisondi, P; Assorgi, C; Bellinato, F; Brianti, P; Burlando, M; Brunasso, G; Caccavale, S; Caldarola, G; Campione, E; Calzavara Pinton, P; Campanati, A; Carrera, Cg; Carugno, A; Cozzani, E; Costanzo, A; Cusano, F; Dapavo, P; Dattola, A; De Simone, C; Di Caprio, R; Diotallevi, F; Fargnoli, Mc; Gaiani, F; Giunta, A; Malagoli, P; Marzano, Av; Megna, M; Mercuri, Sr; Mortato, E; Narcisi, A; Orsini, D; Potestio, L; Quaglino, P; Richetta, Ag; Romano, F; Sena, P; Vagnozzi, E; Venturini, M; Loconsole, F; Balato, A
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: The EARLY study | Mortato, E; Talamonti, M; Marcelli, L; Megna, M; Raimondo, A; Caldarola, G; Bernardini, N; Balato, A; Campanati, A; Esposito, M; Bonifati, C; Lora, V; Potestio, L; Lembo, S; Loconsole, F; De Luca, E; Skroza, N; Buononato, D; Bianchelli, T; Fargnoli, Mc; Tommasino, N; Primavera, F; De Simone, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 13-mar-2026 | AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks | Mortato, E; Talamonti, M; Savastano, L; Marcelli, L; Tofani, L; Gneo, V; Marrapodi, D; Ingrosso, Mr; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-giu-2025 | Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life Study | Mortato, E; Talamonti, M; Paganini, C; Belcastro, A; Tofani, L; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2025 | Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study | Mortato, E; Marcelli, L; Tofani, L; Belcastro, A; Talamonti, M; Paganini, C; Di Raimondo, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 13-mag-2025 | Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis) | Gioacchini, H; Rossi, A; Esposito, M; Vagnozzi, E; Fargnoli, Mc; Gisondi, P; Bellinato, F; Assorgi, C; Brianti, P; Mercuri, Sr; Burlando, M; Cozzani, E; Brunasso, G; Caccavale, S; Balato, A; Caldarola, G; De Simone, C; Campione, E; Giunta, A; Tonon, F; Venturini, M; Carrera, Cg; Marzano, Av; Carugno, A; Sena, P; Costanzo, A; Narcisi, A; Cusano, F; Dapavo, P; Quaglino, P; Dattola, A; Richetta, Ag; Gaiani, F; Malagoli, P; Megna, M; Potestio, L; Mortato, E; Loconsole, F; Romano, F; Faragalli, A; Gesuita, R; Bianchelli, T; Diotallevi, F; Orsini, D; Campanati, A | Articolo su rivista | |
| 6-gen-2026 | Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis | Mortato, E; Marcelli, L; Panichelli, A; Talamonti, M; Gneo, V; Marrapodi, D; Di Raimondo, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2025 | Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study | Mortato, E; Talamonti, M; Marcelli, L; Megna, M; Raimondo, A; Caldarola, G; Bernardini, N; Balato, A; Campanati, A; Esposito, M; Bonifati, C; Lora, V; Potestio, L; Lembo, S; Loconsole, F; De Luca, E; Skroza, N; Buononato, D; Bianchelli, T; Fargnoli, Mc; Tommasino, N; Primavera, F; De Simone, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2026 | Predictive Factors of Super-Responder Status to Dupilumab in Adult Atopic Dermatitis: A Real-World Monocentric Study | Mortato, E; Talamonti, M; Paganini, C; Belcastro, A; Tofani, L; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2025 | Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies | Paganini, C; Mortato, E; Tofani, L; Belcastro, A; Talamonti, M; Di Raimondo, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 15-mag-2025 | Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis) | Esposito, M; Gisondi, P; Assorgi, C; Bellinato, F; Brianti, P; Burlando, M; Brunasso, G; Caccavale, S; Caldarola, G; Campione, E; Calzavara Pinton, P; Campanati, A; Carrera, Cg; Carugno, A; Cozzani, E; Costanzo, A; Cusano, F; Dapavo, P; Dattola, A; De Simone, C; Di Caprio, R; Diotallevi, F; Fargnoli, Mc; Gaiani, F; Giunta, A; Malagoli, P; Marzano, Av; Megna, M; Mercuri, Sr; Mortato, E; Narcisi, A; Orsini, D; Potestio, L; Quaglino, P; Richetta, Ag; Romano, F; Sena, P; Vagnozzi, E; Venturini, M; Loconsole, F; Balato, A | Articolo su rivista |